Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Rebreathing-induced Hypoxia on the Response to an Oral Glucose Tolerance Test

NCT05422430 is registered in ClinicalTrials.gov with University of Texas at Austin as lead sponsor.

NCT NCT05422430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05422430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Rebreathing-induced Hypoxia on the Response to an Oral Glucose Tolerance Test
Lead sponsor
University of Texas at Austin
Phase
Not applicable
Overall status
Completed
Start date
October 21, 2021
Completion date
October 13, 2025
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxemia